www.fdanews.com/articles/177653-cytox-launches-genetic-test-for-alzheimers-disease
Cytox Launches Genetic Test for Alzheimer’s Disease
July 22, 2016
Cytox has launched Variatech, a diagnostic test for Alzheimer’s Disease that relies on genetic biomarkers.
The blood-based test provides a comprehensive panel of AD informative SNPs to assist research and novel drug discovery studies.
Company studies indicate it has an accuracy rate over 80 percent. — Cynthia Jessup